Affiliation:
1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Abstract
Background. Antineoplastic treatment can have late toxic manifestations that can often appear after end of treatment. Children after treatment for acute lymphoblastic leukemia (ALL) have a risk of developing both obesity and undernutrition, which may be concealed by increased fat mass.Objective: to explore the incidence of obesity and hidden undernutrition in children with ALL and to describe the effect of enteral feeding using in these children.Materials and methods. In a retrospective study the data of 62 children with obesity that was revealed by standard examination was analyzed. The criterion of obesity was increased value of fat mass received by bioimpedance analysis. For this evaluation Russian bioimpedance analysis standards were used. Additionally, the included data were following: presence of endocrine pathology, weight change during latter 6 months before admission, physical activity and alimentary characteristics (usual regimen and structure of daily feed).Results. Only 54.8 % of patients with an actual excess of fat body mass index detected obesity (Z‑score higher than +2.00) and another 29 % body mass index was within the normal range (Z‑score from –1.00 to +1.00). This was the result of a tissue imbalance: reduce fat‑free mass. Some patients were diagnosed with insulin resistance and hyperinsulinemia. 83.7 % have a completely passive lifestyle. 49.0 % almost do not eat fruits and berries, 79.6 % – vegetables and 91.8 % – fish and seafood. Frequent intake of sweet dishes – 22.4 %, sausage products – 49.0 %, bakery products – 42.9 %, dishes from fast food restaurants – 42.9 %. 55.1 % of patients had more than 5 meals a day, while 18.4 % – less than 3. In or‑ der to correct hidden nutritional deficiencies, 22 patients received artificial nutritional formulas. They had a significant increase in fat‑free mass and a decrease in fat, in comparison with those who did not receive enteral feeding.Conclusion. Treatment‑associated factors, physical activity and alimentary causes play an important role in formation of not only obesity, but also hidden nutritional insufficiency in children with ALL after treatment. Enteral feeding using artificial polymeric formulas showed its effectiveness. An integrated and multidisciplinary approach to solving the problem is appropriate of prevention and treatment of obesity.
Publisher
Publishing House ABV Press
Reference23 articles.
1. Margolin J.F., Steuber C.P., Poplack D.G. Acute lymphoblastic leukemia. In: Principles and Practice of Pediatric Oncology. 5th ed. Eds.: P.A. Pizzo, D.G. Poplack. Philadelphia: Lippincott Williams & Wilkins, 2006. Pp. 538–590.
2. Barr R.D., Furlong W., Dawson S. et al. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol 1993;15(3):284–90.
3. Nuver J., Smit A.J., Postma A. et al. The metabolic syndrome in longterm cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002;28(4):195–214. DOI: 10.1016/s03057372(02)000385.
4. Zareifar S., Shorafa S., Haghpanah S. et al. Association of serum leptin level with obesity in children with acute lymphoblastic leukemia. Iran J Ped Hematol Oncol 2015;5(3):116–24.
5. Zhang F.F., Rodday A.M., Kelly M.J. et al. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2014;61(7):1263–9. DOI: 10.1002/pbc.24960.